Table 2 In vitro antibacterial activity of the target compounds against Xaca
From: Carbene-catalyzed chemoselective reaction of unsymmetric enedials for access to Furo[2,3-b]pyrroles
Compounds | Xanthomonas axonopodis pv. citri (Xac) Inhibition rate / % | |
|---|---|---|
3a | 57.15 ± 1.21 (230 μM/L) | 26.77 ± 2.01 (120 μM/L) |
3a(D) | 56.94 ± 1.15 (230 μM/L) | 30.27 ± 2.45 (120 μM/L) |
3b | 95.81 ± 4.01 (220 μM/L) | 37.96 ± 1.17 (110 μM/L) |
3d | 46.24 ± 0.40 (220 μM/L) | 33.23 ± 0.17 (110 μM/L) |
3e | 50.97 ± 0.35 (220 μM/L) | 33.28 ± 1.82 (110 μM/L) |
3f | 46.40 ± 0.85 (220 μM/L) | 30.65 ± 0.66 (110 μM/L) |
3g | 46.67 ± 7.18 (210 μM/L) | 35.91 ± 0.21 (110 μM/L) |
3i | 97.42 ± 0.80 (220 μM/L) | 35.70 ± 1.50 (110 μM/L) |
4d | 73.06 ± 1.97 (220 μM/L) | 28.01 ± 6.41 (110 μM/L) |
4f | 55.86 ± 4.89 (220 μM/L) | 36.45 ± 7.58 (110 μM/L) |
4i | 90.48 ± 2.21 (220 μM/L) | 53.66 ± 0.87 (110 μM/L) |
4k | 67.31 ± 0.40 (220 μM/L) | 50.86 ± 2.48 (110 μM/L) |
4q | 65.48 ± 0.82 (240 μM/L) | 40.27 ± 4.29 (120 μM/L) |
4r | 27.80 ± 1.05 (230 μM/L) | 23.98 ± 0.84 (110 μM/L) |
5 | 68.92 ± 0.68 (200 μM/L) | 36.40 ± 5.95 (100 μM/L) |
6 | 89.62 ± 1.32 (290 μM/L) | 80.43 ± 5.56 (140 μM/L) |
7 | 94.78 ± 0.42 (360 μM/L) | 80.16 ± 0.40 (180 μM/L) |
8 | 92.31 ± 5.16 (230 μM/L) | 39.35 ± 2.61 (110 μM/L) |
Thiodiazole copperb | 57.11 ± 4.48 (300 μM/L) | 27.90 ± 2.14 (150 μM/L) |
Bismerthiazolb | 94.52 ± 1.84 (360 μM/L) | 55.22 ± 3.44 (180 μM/L) |
